Drug Trial Radar · NCT00091312
Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Last checked: Nov 19, 2026Latest source record: Feb 9, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,976
Planned (sponsor's estimate)
Start
Jun 2004
Primary completion
Not stated
Sponsor
- Lead sponsor
- Federation Francophone de Cancerologie DigestiveAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 9, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy, such as irinotecan, leucovorin, and fluorouracil, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them after surgery may kill any remaining tumor cells. It is not yet known whether combination chemotherapy is more effective than observation alone in treating patients who have undergone surgery for colon cancer. PURPOSE: This randomized phase III trial is studying irinotecan and fluorouracil with or without leucovorin to see how well they work compared to observation alone in treating patients who have undergone surgery for stage II colon cancer.
Conditions
- Colorectal Cancer
Interventions
FOLFIRI regimenDrug
fluorouracilDrug
irinotecan hydrochlorideDrug
leucovorin calciumDrug
adjuvant therapyProcedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-free survival at 5 years
Locations
9 sites in 6 countries. Site status is shown where the registry gives one.
National Cancer Institute - Cairo
Cairo, Egypt
Centre Hospitalier Universitaire Ambroise Pare - Boulogne
Boulogne-Billancourt, France
Hopital Du Bocage
Dijon, France
Medizinische Klinik I
Dresden, Germany
Ospedali Riuniti di Bergamo
Bergamo, Italy
Azienda Ospedaliero Careggi
Florence, Italy
Universita Degli Studi di Florence - Policlinico di Careggi
Florence, Italy
Instituto Portugues de Oncologia Centro do Porto, S. A.
Porto, Portugal
Hospital Universitario de Elche
Elche Alicante, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.